77 related articles for article (PubMed ID: 30951934)
1. A tetravalent single chain diabody (CD40/HER2) efficiently inhibits tumor proliferation through recruitment of T cells and anti-HER2 functions.
Lu L; Liu N; Fan K; Zhang G; Li C; Yan Y; Liu T; Fu WH
Mol Immunol; 2019 May; 109():149-156. PubMed ID: 30951934
[TBL] [Abstract][Full Text] [Related]
2. Selection and expression of CD40 single chain variable fragment by phage display and evaluation of tumor specific immune activation.
Lu L; Wang X; Zhang A; Huang F; Yan Y; Li W; Fu W
Int Immunopharmacol; 2019 Jun; 71():224-232. PubMed ID: 30925323
[TBL] [Abstract][Full Text] [Related]
3. Rearranging the domain order of a diabody-based IgG-like bispecific antibody enhances its antitumor activity and improves its degradation resistance and pharmacokinetics.
Asano R; Shimomura I; Konno S; Ito A; Masakari Y; Orimo R; Taki S; Arai K; Ogata H; Okada M; Furumoto S; Onitsuka M; Omasa T; Hayashi H; Katayose Y; Unno M; Kudo T; Umetsu M; Kumagai I
MAbs; 2014; 6(5):1243-54. PubMed ID: 25517309
[TBL] [Abstract][Full Text] [Related]
4. A scDb-based trivalent bispecific antibody for T-cell-mediated killing of HER3-expressing cancer cells.
Aschmoneit N; Steinlein S; Kühl L; Seifert O; Kontermann RE
Sci Rep; 2021 Jul; 11(1):13880. PubMed ID: 34230555
[TBL] [Abstract][Full Text] [Related]
5. Cloning, expression, purification and characterization of a bispecific single-chain diabody against fluoroquinolones and sulfonamides in Escherichia coli.
Chen M; Wen K; Tao X; Xie J; Wang L; Li Y; Ding S; Jiang H
Protein Expr Purif; 2014 Aug; 100():19-25. PubMed ID: 24816423
[TBL] [Abstract][Full Text] [Related]
6. The effects of affinity and valency of an albumin-binding domain (ABD) on the half-life of a single-chain diabody-ABD fusion protein.
Hopp J; Hornig N; Zettlitz KA; Schwarz A; Fuss N; Müller D; Kontermann RE
Protein Eng Des Sel; 2010 Nov; 23(11):827-34. PubMed ID: 20817756
[TBL] [Abstract][Full Text] [Related]
7. [Construction and expression of an anti-EGFR/anti-KDR bispecific single-chain diabody].
Zhou YQ; Zhang J; Jin HZ; He Y; Wang T; Wang M
Yao Xue Xue Bao; 2012 Oct; 47(10):1317-22. PubMed ID: 23289143
[TBL] [Abstract][Full Text] [Related]
8. Harnessing the hERG1/β1 Integrin Complex via a Novel Bispecific Single-chain Antibody: An Effective Strategy against Solid Cancers.
Duranti C; Iorio J; Lottini T; Lastraioli E; Crescioli S; Bagni G; Lulli M; Capitani C; Bouazzi R; Stefanini M; Carraresi L; Iamele L; De Jonge H; Arcangeli A
Mol Cancer Ther; 2021 Aug; 20(8):1338-1349. PubMed ID: 34045227
[TBL] [Abstract][Full Text] [Related]
9. [Specific cytotoxicity of a novel HER2-based chimeric antigen receptor modified T lymphocytes against HER2-positive tumor cells].
Tang HJ; Liu YQ; Bian XC; Feng HL; Gu B; Sun H; Zuo CX; Zhou FY; Liu J
Zhonghua Bing Li Xue Za Zhi; 2017 Oct; 46(10):714-720. PubMed ID: 29050075
[No Abstract] [Full Text] [Related]
10. A novel tri-functional antibody fusion protein with improved pharmacokinetic properties generated by fusing a bispecific single-chain diabody with an albumin-binding domain from streptococcal protein G.
Stork R; Müller D; Kontermann RE
Protein Eng Des Sel; 2007 Nov; 20(11):569-76. PubMed ID: 17982179
[TBL] [Abstract][Full Text] [Related]
11. Inhibition activity of a disulfide-stabilized diabody against basic fibroblast growth factor in lung cancer.
Cai Y; Yao S; Zhong J; Zhang J; Jiang H; Deng Y; Deng N
Oncotarget; 2017 Mar; 8(12):20187-20197. PubMed ID: 28423625
[TBL] [Abstract][Full Text] [Related]
12. Reduced Tumor Volume and Increased Necrosis of Human Breast Tumor Xenograft in Mice Pretreated by a Cocktail of Three Specific Anti-HER2 scFvs.
Nejatollahi F; Nadimi E; Noorafshan A; Moazen S; Alizadeh AM; Khalighfard S; Sahebkar A
Curr Protein Pept Sci; 2024; 25(5):409-418. PubMed ID: 38018211
[TBL] [Abstract][Full Text] [Related]
13. Optimized Expression and Characterization of a Novel Fully Human Bispecific Single-Chain Diabody Targeting Vascular Endothelial Growth Factor165 and Programmed Death-1 in
Xiong C; Mao Y; Wu T; Kang N; Zhao M; Di R; Li X; Ji X; Liu Y
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30257416
[TBL] [Abstract][Full Text] [Related]
14. Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice.
Wei H; Wang S; Zhang D; Hou S; Qian W; Li B; Guo H; Kou G; He J; Wang H; Guo Y
Clin Cancer Res; 2009 Jul; 15(14):4612-21. PubMed ID: 19584156
[TBL] [Abstract][Full Text] [Related]
15. Bispecific single-chain diabody-immunoliposomes targeting endoglin (CD105) and fibroblast activation protein (FAP) simultaneously.
Rabenhold M; Steiniger F; Fahr A; Kontermann RE; Rüger R
J Control Release; 2015 Mar; 201():56-67. PubMed ID: 25617725
[TBL] [Abstract][Full Text] [Related]
16. Expression and characterization of recombinant humanized anti-HER2 single-chain antibody in Pichia pastoris for targeted cancer therapy.
Cao X; Yu H; Chen C; Wei J; Wang P
Biotechnol Lett; 2015 Jul; 37(7):1347-54. PubMed ID: 25735855
[TBL] [Abstract][Full Text] [Related]
17. Improved biological activity of a single chain antibody fragment against human epidermal growth factor receptor 2 (HER2) expressed in the periplasm of Escherichia coli.
Akbari V; Sadeghi HM; Jafarian-Dehkordi A; Abedi D; Chou CP
Protein Expr Purif; 2015 Dec; 116():66-74. PubMed ID: 26166178
[TBL] [Abstract][Full Text] [Related]
18. A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2.
Biburger M; Weth R; Wels WS
J Mol Biol; 2005 Mar; 346(5):1299-311. PubMed ID: 15713482
[TBL] [Abstract][Full Text] [Related]
19. A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19(+) tumor cells.
Reusch U; Duell J; Ellwanger K; Herbrecht C; Knackmuss SH; Fucek I; Eser M; McAleese F; Molkenthin V; Gall FL; Topp M; Little M; Zhukovsky EA
MAbs; 2015; 7(3):584-604. PubMed ID: 25875246
[TBL] [Abstract][Full Text] [Related]
20. Selective cytotoxicity to HER2-positive tumor cells by a recombinant e23sFv-TD-tBID protein containing a furin cleavage sequence.
Wang F; Ren J; Qiu XC; Wang LF; Zhu Q; Zhang YQ; Huan Y; Meng YL; Yao LB; Chen SY; Xu YM; Yang AG
Clin Cancer Res; 2010 Apr; 16(8):2284-94. PubMed ID: 20371697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
